Thanks to its most recent acquisition, Vertex now has some promising products in the field of hormone disorders. These could eventually become meaningful growth drivers for the company.
Latigo Biotherapeutics is undervalued below IPO, with onzotrigine showing superior efficacy to Vertex's Journavx in acute pain. LTGO leverages Vertex's market groundwork, has pivotal-eligible Phase 2 data, and is funded into 2029, reducing near-term financing risk. Onzotrigine's Phase 3 bunionectomy trial is the key binary event; positive results could drive significant upside versus current market expectations.
Vertex Pharmaceuticals NASDAQ: VRTX is continuing to broaden its business beyond cystic fibrosis, with its renal medicine portfolio, rare endocrine assets and cell therapies among the company's priorities, CEO and President Reshma Kewalramani said at Morgan Stanley's 24th Annual Healthcare Conference.
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
Curtis Ellergodt Rothschild Investment LLC | 198 | $2,943.65 | $2,704.68 | -$238.97 | -8.12% |
| NA Nizar Araji National Bank Of Canada /FI/ | 1 | $11.89 | $13.66 | $1.77 | 14.89% |
| SN Stephanie Nee HARBOR CAPITAL ADVISORS Inc. | 18,580 | $220,916.2 | $249,622.3 | $28,706.1 | 12.99% |
| WC Wayne Cohen Sculptor Capita LLP | 59,200 | $679,616 | $783,216 | $103,600 | 15.24% |
| BG Bart Gancher Intech Investment Management LLC | 19,527 | $728,995.44 | $266,738.82 | -$462,256.62 | -63.41% |
| Software Industry | Information Technology Sector | Christopher David Young CEO | NASDAQ (NMS) Exchange | 92538J106 CUSIP |
| US Country | 2,000 Employees | - Last Dividend | - Last Split | 29 Jul 2020 IPO Date |
Vertex, Inc., established in 1978 and based in King of Prussia, Pennsylvania, operates internationally, offering cutting-edge tax technology solutions tailored for the retail trade, wholesale trade, and manufacturing industries. The company specializes in helping enterprises navigate the complex landscape of tax determination, compliance, reporting, and data management through a suite of products and services delivered both as traditional software licenses and modern Software as a Service (SaaS) subscriptions. With a focus on innovation, Vertex, Inc. leverages its extensive experience and industry-specific insights to provide comprehensive tax technology solutions designed to meet the evolving needs of its global clientele.